ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #16,806Hybrid

Hemoglobin

Abbreviation (ISO):HEMOGLOBIN
•
Identifier (ISSN):0363-0269(Print)/1532-432X(Online)
•
Publisher:Informa Healthcare
Clarivate IF (2026)
1– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Hemoglobin

WoS Q4
01120.4620180.620190.5320200.8520210.822022120231.220241202512026
Annual Impact Factor Metric
Current (2026):1
Scopus SJR & RankScopus Q3
0.311
#16,806

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
48

48 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate8.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
63articles/year
3.28% Gold OA•72.73% Original Research

Aims & Scope

Hemoglobin is a journal in the English language for the communication of research and information concerning hemoglobin in humans and other species. Hemoglobin publishes articles, reviews, points of view The journal covers topics such as: structure, function, genetics and evolution of hemoglobins biochemical and biophysical properties of hemoglobin molecules characterization of hemoglobin disorders (variants and thalassemias), consequences and treatment of hemoglobin disorders epidemiology and prevention of hemoglobin disorders (neo-natal and adult screening) modulating factors methodology used for diagnosis of hemoglobin disorders

Topics Covered (Recognized by AI)
Biology90.5%Chemistry87.5%Medicine84.7%Internal medicine81.4%Genetics77.9%Biochemistry76.8%Organic chemistry55.6%Gene51%Hemoglobin48.4%Thalassemia41.6%Molecular biology35.4%Pathology33.7%Mutation27.8%Disease26.8%Immunology26.3%Psychology21.6%Physics20.1%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q4
Rank313/328
IndexSCIE
JCRSCIE2026

HEMATOLOGY

Q4
Rank87/103
IndexSCIE
JCISCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q4
Rank314/328
IndexSCIE
JCISCIE2026

HEMATOLOGY

Q4
Rank89/103
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1
Articles / Year56
Total Citations5
2025
IF1
Articles / Year75
Total Citations44
2024
IF1.2
Articles / Year69
Total Citations102
2023
IF1
Articles / Year41
Total Citations147
2022
IF0.822
Articles / Year70
Total Citations439

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #16,806Scopus Q3SCImago Profile
Scopus Coverage:1976-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q3
0.311

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
0.93

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,654 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations218
3-Year Documents181
Citable Documents173

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biochemistry (medical)Q3
HematologyQ3
Clinical BiochemistryQ4
Genetics (clinical)Q4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 8.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区BIOCHEMISTRY & MOLECULAR BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Hemoglobin (abbr: HEMOGLOBIN, ISSN: 0363-0269) is a peer-reviewed international scholarly journal in the field of Medicine, published by Informa Healthcare in United States since 1976. The periodical holds a Journal Impact Factor (JIF) of 1.00, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.311 (Q3), an H-index of 48.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 63 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,654 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Informa Healthcare
Publication Language
English
Frequency
Quarterly
Founding Year
1976
Indexing & Databases
SCIEScopusPubMed
Editorial Address
TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 01935218-8aef-4000-ae1d-2be66af70b6b
Database Updated: 2026-10-01